Merck KGaA (MRK):企業の財務・戦略的SWOT分析

GlobalDataが発行した調査報告書(SWOT20MY1667)
◆英語タイトル:Merck KGaA (MRK) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1667
◆発行会社(リサーチ会社):GlobalData
◆発行日:2020年4月
◆ページ数:82
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:ドイツ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,125見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,375見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Merck KGaA (MRK) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Merck KGaA (Merck), a subsidiary of E. Merck KG, is a science and technology company. It discovers, develops and manufactures prescription drugs to treat cancer, multiple sclerosis and infertility; and develops liquid crystal mixtures, organic light-emitting diodes (OLED) materials and cosmetic active ingredients. Merck also provides a wide range of products including lab water systems, gene editing tools, cell lines, antibodies and end-to-end systems. The company serves healthcare, performance materials and life sciences markets. It has presence in Europe, North America, Asia-Pacific, Latin America and Middle East and Africa. Merck is headquartered in Darmstadt, Hesse, Germany.

Merck KGaA Key Recent Developments

Apr 28,2020 Merck signs Covid-19 research alliance with ISB
Apr 21,2020 Merck broadens patient support and assistance programs as part of overall COVID-19 relief efforts
Apr 17,2020 Merck is supporting Darmstadt in the Covid-19 crisis
Mar 27,2020 Novartis partners with life sciences companies to fight Covid-19

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Merck KGaA – Key Facts
Merck KGaA – Key Employees
Merck KGaA – Key Employee Biographies
Merck KGaA – Major Products and Services
Merck KGaA – History
Merck KGaA – Company Statement
Merck KGaA – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Merck KGaA – Business Description
Business Segment: Healthcare
Overview
Performance
Business Segment: Life Science
Overview
Performance
Business Segment: Performance Materials
Overview
Performance
Geographical Segment: Asia-Pacific
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Latin America
Performance
Geographical Segment: Middle East and Africa (MEA)
Performance
Geographical Segment: North America
Performance
R&D Overview
Merck KGaA – Corporate Strategy
Merck KGaA – SWOT Analysis
SWOT Analysis – Overview
Merck KGaA – Strengths
Merck KGaA – Weaknesses
Merck KGaA – Opportunities
Merck KGaA – Threats
Merck KGaA – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Merck KGaA, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Merck KGaA, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Merck KGaA, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 28, 2020: Merck signs Covid-19 research alliance with ISB
Apr 21, 2020: Merck broadens patient support and assistance programs as part of overall COVID-19 relief efforts
Apr 17, 2020: Merck is supporting Darmstadt in the Covid-19 crisis
Mar 27, 2020: Novartis partners with life sciences companies to fight Covid-19
Mar 26, 2020: Novartis and life sciences companies commit expertise and assets to the fight against COVID-19 pandemic alongside Bill & Melinda Gates Foundation
Mar 05, 2020: Physiomics awarded further contract by Merck
Mar 03, 2020: Merck’s new Lanexo system to improve scientists productivity in the lab
Feb 27, 2020: Merck and AMCM / EOS Cooperate in 3D Printing of Tablets
Feb 06, 2020: Merck plans spinoff to focus on core areas to achieve faster growth
Jan 28, 2020: Merck to build $275m biotech development plant in Switzerland
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Merck KGaA, Key Facts
Merck KGaA, Key Employees
Merck KGaA, Key Employee Biographies
Merck KGaA, Major Products and Services
Merck KGaA, History
Merck KGaA, Subsidiaries
Merck KGaA, Key Competitors
Merck KGaA, Ratios based on current share price
Merck KGaA, Annual Ratios
Merck KGaA, Annual Ratios (Cont...1)
Merck KGaA, Annual Ratios (Cont...2)
Merck KGaA, Interim Ratios
Merck KGaA, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Merck KGaA, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Merck KGaA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Merck KGaA, Performance Chart (2015 - 2019)
Merck KGaA, Ratio Charts
Merck KGaA, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Merck KGaA, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Merck KGaA (MRK):企業の財務・戦略的SWOT分析(Merck KGaA (MRK) - Financial and Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆